143 related articles for article (PubMed ID: 22026127)
1. Hepatotoxicity of silica nanoparticles with a diameter of 100 nm.
Hasezaki T; Isoda K; Kondoh M; Tsutsumi Y; Yagi K
Pharmazie; 2011 Sep; 66(9):698-703. PubMed ID: 22026127
[TBL] [Abstract][Full Text] [Related]
2. Liver injury induced by thirty- and fifty-nanometer-diameter silica nanoparticles.
Isoda K; Tetsuka E; Shimizu Y; Saitoh K; Ishida I; Tezuka M
Biol Pharm Bull; 2013; 36(3):370-5. PubMed ID: 23268881
[TBL] [Abstract][Full Text] [Related]
3. Influence of 50-nm polystyrene particles in inducing cytotoxicity in mice co-injected with carbon tetrachloride, cisplatin, or paraquat.
Shimizu Y; Isoda K; Tezuka E; Yufu T; Nagai Y; Ishida I; Tezuka M
Pharmazie; 2012 Aug; 67(8):712-4. PubMed ID: 22957437
[TBL] [Abstract][Full Text] [Related]
4. Influence of 70 nm silica particles in mice with cisplatin or paraquat-induced toxicity.
Nishimori H; Kondoh M; Isoda K; Tsunoda S; Tsutsumi Y; Yagi K
Pharmazie; 2009 Jun; 64(6):395-7. PubMed ID: 19618677
[TBL] [Abstract][Full Text] [Related]
5. Effect of surface charge on nano-sized silica particles-induced liver injury.
Isoda K; Hasezaki T; Kondoh M; Tsutsumi Y; Yagi K
Pharmazie; 2011 Apr; 66(4):278-81. PubMed ID: 21612155
[TBL] [Abstract][Full Text] [Related]
6. Effects of surface charge and palladium on hepatic and kidney injury induced by polystyrene nanoparticles co-administered to mice with paraquat and cisplatin.
Isoda K; Nozawa T; Taira Y; Taira I; Shimizu Y; Ishida I
Pharmazie; 2018 Mar; 73(3):165-168. PubMed ID: 29544565
[TBL] [Abstract][Full Text] [Related]
7. Silica nanoparticles as hepatotoxicants.
Nishimori H; Kondoh M; Isoda K; Tsunoda S; Tsutsumi Y; Yagi K
Eur J Pharm Biopharm; 2009 Aug; 72(3):496-501. PubMed ID: 19232391
[TBL] [Abstract][Full Text] [Related]
8. Modifying the Surface of Silica Nanoparticles with Amino or Carboxyl Groups Decreases Their Cytotoxicity to Parenchymal Hepatocytes.
Nagano T; Nagano K; Nabeshi H; Yoshida T; Kamada H; Tsunoda SI; Gao JQ; Higashisaka K; Yoshioka Y; Tsutsumi Y
Biol Pharm Bull; 2017; 40(5):726-728. PubMed ID: 28458361
[TBL] [Abstract][Full Text] [Related]
9. Hepatotoxicity of sub-nanosized platinum particles in mice.
Yamagishi Y; Watari A; Hayata Y; Li X; Kondoh M; Tsutsumi Y; Yagi K
Pharmazie; 2013 Mar; 68(3):178-82. PubMed ID: 23556335
[TBL] [Abstract][Full Text] [Related]
10. Integrated metabonomics analysis of the size-response relationship of silica nanoparticles-induced toxicity in mice.
Lu X; Tian Y; Zhao Q; Jin T; Xiao S; Fan X
Nanotechnology; 2011 Feb; 22(5):055101. PubMed ID: 21178262
[TBL] [Abstract][Full Text] [Related]
11. Hepatotoxicity, nephrotoxicity, and drug/chemical interaction toxicity of platinum nanoparticles in mice.
Isoda K; Daibo T; Yushina K; Yoshioka Y; Tsutsumi Y; Akimoto Y; Kawakami H; Taira Y; Taira I; Yanoshita R; Nishimura T; Ishida I
Pharmazie; 2017 Jan; 72(1):10-16. PubMed ID: 29441891
[TBL] [Abstract][Full Text] [Related]
12. The impact of size on tissue distribution and elimination by single intravenous injection of silica nanoparticles.
Cho M; Cho WS; Choi M; Kim SJ; Han BS; Kim SH; Kim HO; Sheen YY; Jeong J
Toxicol Lett; 2009 Sep; 189(3):177-83. PubMed ID: 19397964
[TBL] [Abstract][Full Text] [Related]
13. Histological analysis of 70-nm silica particles-induced chronic toxicity in mice.
Nishimori H; Kondoh M; Isoda K; Tsunoda S; Tsutsumi Y; Yagi K
Eur J Pharm Biopharm; 2009 Aug; 72(3):626-9. PubMed ID: 19341796
[TBL] [Abstract][Full Text] [Related]
14. Liver-specific microRNAs as biomarkers of nanomaterial-induced liver damage.
Nagano T; Higashisaka K; Kunieda A; Iwahara Y; Tanaka K; Nagano K; Abe Y; Kamada H; Tsunoda S; Nabeshi H; Yoshikawa T; Yoshioka Y; Tsutsumi Y
Nanotechnology; 2013 Oct; 24(40):405102. PubMed ID: 24029385
[TBL] [Abstract][Full Text] [Related]
15. Identifying a size-specific hazard of silica nanoparticles after intravenous administration and its relationship to the other hazards that have negative correlations with the particle size in mice.
Handa T; Hirai T; Izumi N; Eto SI; Tsunoda SI; Nagano K; Higashisaka K; Yoshioka Y; Tsutsumi Y
Nanotechnology; 2017 Mar; 28(13):135101. PubMed ID: 28240988
[TBL] [Abstract][Full Text] [Related]
16. Use of Zebrafish Larvae as a Multi-Endpoint Platform to Characterize the Toxicity Profile of Silica Nanoparticles.
Pham DH; De Roo B; Nguyen XB; Vervaele M; Kecskés A; Ny A; Copmans D; Vriens H; Locquet JP; Hoet P; de Witte PA
Sci Rep; 2016 Nov; 6():37145. PubMed ID: 27872490
[TBL] [Abstract][Full Text] [Related]
17. In vivo investigation on the chronic hepatotoxicity induced by intraperitoneal administration of 10-nm silicon dioxide nanoparticles.
Almansour M; Alarifi S; Jarrar B
Int J Nanomedicine; 2018; 13():2685-2696. PubMed ID: 29765215
[TBL] [Abstract][Full Text] [Related]
18. In vivo toxicologic study of larger silica nanoparticles in mice.
Chan WT; Liu CC; Chiang Chiau JS; Tsai ST; Liang CK; Cheng ML; Lee HC; Yeung CY; Hou SY
Int J Nanomedicine; 2017; 12():3421-3432. PubMed ID: 28496319
[TBL] [Abstract][Full Text] [Related]
19. Hepatotoxicity and liver injury induced by hydroxyapatite nanoparticles.
Chen Q; Xue Y; Sun J
J Appl Toxicol; 2014 Nov; 34(11):1256-64. PubMed ID: 25225040
[TBL] [Abstract][Full Text] [Related]
20. Size-dependent cytotoxic effects of amorphous silica nanoparticles on Langerhans cells.
Nabeshi H; Yoshikawa T; Matsuyama K; Nakazato Y; Arimori A; Isobe M; Tochigi S; Kondoh S; Hirai T; Akase T; Yamashita T; Yamashita K; Yoshida T; Nagano K; Abe Y; Yoshioka Y; Kamada H; Imazawa T; Itoh N; Tsunoda S; Tsutsumi Y
Pharmazie; 2010 Mar; 65(3):199-201. PubMed ID: 20383940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
